These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16113361)

  • 1. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.
    García-Arumí J; Boixadera A; Giralt J; Martinez-Castillo V; Gomez-Ulla F; Corcostegui B; García-Arumí E
    Br J Ophthalmol; 2005 Sep; 89(9):1112-4. PubMed ID: 16113361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of benzyl alcohol from a commercially available triamcinolone acetonide suspension for intravitreal use.
    Hernaez-Ortega MC; Soto-Pedre E
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):162-4. PubMed ID: 16583642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Triamcinolone acetonide without solvents].
    Martínez Rubio M; Moya Moya M; Selva Otaola-Urruchi J; Martínez Lazcano T; Belmonte Martínez J
    Arch Soc Esp Oftalmol; 2012 Oct; 87(10):320-3. PubMed ID: 23021229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different purification techniques on triamcinolone yield and particle size spectrum.
    Szurman P; Kaczmarek R; Jaissle GB; Grisanti S; Lüke M; Spitzer MS; Heide PE; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):689-96. PubMed ID: 17006679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
    Korodi T; Lachmann B; Kopelent-Frank H
    Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.
    Hernaez-Ortega MC; Soto-Pedre E
    Ophthalmic Surg Lasers Imaging; 2004; 35(4):350-1. PubMed ID: 15305565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal injection of triamcinolone acetonide.
    Soto-Pedre E; Hernaez-Ortega MC
    Acta Ophthalmol Scand; 2007 Mar; 85(2):234; author reply 234-5. PubMed ID: 17305752
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter.
    Nishimura A; Kobayashi A; Segawa Y; Sakurai M; Shirao E; Shirao Y; Sugiyama K
    Retina; 2003 Dec; 23(6):777-9. PubMed ID: 14707826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of triamcinolone acetonide suspension for intravitreal use: the centrifugation method.
    Hernaez-Ortega MC; Soto-Pedre E
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):473-4. PubMed ID: 19642910
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservative-free triamcinolone acetonide suspension developed for intravitreal injection.
    Bitter C; Suter K; Figueiredo V; Pruente C; Hatz K; Surber C
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):62-9. PubMed ID: 18370876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of triamcinolone acetonide suspension for intravitreal injection.
    Soto-Pedre E
    Br J Ophthalmol; 2006 Jan; 90(1):123-4. PubMed ID: 16361689
    [No Abstract]   [Full Text] [Related]  

  • 12. Triamcinolone acetonide concentration after filtration of the solvent agent.
    Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Sagstetter BU; Stiefvater K; Jonas JB
    Am J Ophthalmol; 2005 Apr; 139(4):712-3. PubMed ID: 15808171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of sedimented triamcinolone for intravitreal injection.
    Tsong JW; Persaud TO; Mansour SE
    Retina; 2007; 27(9):1255-9. PubMed ID: 18046234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection.
    Ober MD; Barile GR; Tari SR; Tosi GM; Schiff WM; Chang S
    Am J Ophthalmol; 2006 Oct; 142(4):597-600. PubMed ID: 17011851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.
    Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Jonas JB
    Br J Ophthalmol; 2005 Aug; 89(8):999-1003. PubMed ID: 16024853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide concentration after subtenon injection.
    Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
    Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.
    Kube T; Sutter M; Trittler R; Feltgen N; Hansen LL; Agostini HT
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1385-90. PubMed ID: 16715253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide.
    Li Y; Chen H; Hou J; Zhang Y; Li G; Gu X; Luo L; Shen H; Qu J; Cheng L
    Retina; 2012 Feb; 32(2):364-74. PubMed ID: 21909054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.